RIGHT REMEDIES Maximum Strength Diuretic Pamabrom 50 mg Capsule, Liquid Filled, 120-count — NDC 70692-595-12 (Billing 70692-0595-12)
This is a package of 120 capsules of RIGHT REMEDIES Maximum Strength Diuretic Pamabrom 50 mg Capsule, Liquid Filled from Strive Pharmaceuticals Inc., marketed since May 2025 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 832080
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Right Remedies Maximum Strength Diuretic is an oral liquid-filled capsule containing pamabrom, an active ingredient in over-the-counter diuretic products. Pamabrom is typically used to help reduce water retention and bloating. This product is marketed under the FDA's OTC monograph rules for diuretics, which means it follows established safety and effectiveness standards for its category rather than undergoing individual FDA review.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70692-0595-12 You're viewing this Main listing | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE | 2025-05-07 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Pamabrom 50 mg 00363-0795-84 | WALGREENS | 48 capsules | — | — | FDA listed | — |
| Pamabrom 50 mg 35916-1654-01 | Softgel | 48 capsules | — | — | FDA listed | — |
| RIGHT REMEDIES Maximum Strength Diuretic 50 mgthis 70692-0595-12 | Strive | 120 capsules | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses For the relief of • temporary water weight gain • bloating • swelling • full feeling associated with the premenstrual and menstrual periods
⏱️ Dosage and Administration ▾
Directions • Use only as directed. • Adults: One (1) softgel after breakfast with a full glass of water. • Dose may be repeated after 6 hours, not to exceed four (4) softgels in 24 hours. • Start taking 5 or 6 days before onset of period and continue until desired relief is obtained or end of period. • Drink 6 to 8 glasses of water daily. • For use by normally healthy adults only. • Persons under 18 years of age should use only as directed by a doctor.
⚠️ Warnings ▾
Warnings Ask a doctor or pharmacist before use if you are taking any other medication. Stop use and ask a doctor if symptoms last for more than ten consecutive days. If pregnant or breast-feeding, ask a health professional before use.
📦 Storage and Handling ▾
Other information • store at room temperature between 20°–25°C (68°–77°F) • protect from light, heat and moisture
🧪 Active Ingredient ▾
Active ingredient (in each softgel) Pamabrom 50 mg
🧪 Inactive Ingredients ▾
Inactive ingredients FD&C Blue No. 1, gelatin, glycerin, polyethylene glycol 400, povidone, propylene glycol, purified water, sorbitol sorbitan solution, titanium dioxide
🎯 Purpose ▾
Purpose Diuretic
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.
📄 Questions or Comments ▾
Questions or comments? 1-888-577-8033 Monday - Friday 8am - 4pm EST
📄 Package Label / Principal Display Panel ▾
Packaging Maximum Strength Diuretic
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |